Johnson & Johnson Ownership | Who Owns Johnson & Johnson?
Johnson & Johnson Ownership Summary
Johnson & Johnson is owned by 72.48% institutional investors, 0.06% insiders, and 27.46% retail investors. Vanguard group is the largest institutional shareholder, holding 9.67% of JNJ shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 3.17% of its assets in Johnson & Johnson shares.
JNJ Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Johnson & Johnson | 72.48% | 0.06% | 27.46% |
| Sector | Healthcare Stocks | 488.30% | 11.08% | -399.38% |
| Industry | Drug Manufacturers - General Stocks | 50.22% | 2.50% | 47.29% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Vanguard group | 232.79M | 9.67% | $33.67B |
| Blackrock funding, inc. /de | 203.85M | 8.43% | $31.14B |
| Blackrock | 198.19M | 8.23% | $28.97B |
| State street | 133.09M | 5.53% | $19.45B |
| Geode capital management | 57.67M | 2.40% | $8.32B |
| Morgan stanley | 42.07M | 1.75% | $6.15B |
| Jpmorgan chase | 38.78M | 1.61% | $5.61B |
| State farm mutual automobile insurance | 31.68M | 1.31% | $4.84B |
| Norges bank | 30.36M | 1.26% | $4.39B |
| Northern trust | 28.43M | 1.18% | $4.16B |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Robert wood johnson foundation | 345.15K | 46.57% | $52.72M |
| Journey strategic wealth | 7.04M | 38.05% | $1.02B |
| Mitsubishi ufj morgan stanley securities | 18.30K | 33.91% | $2.67M |
| Mayar capital | 65.14K | 18.29% | $9.95M |
| Ardent capital management | 151.89K | 11.13% | $23.20M |
| Cincinnati indemnity | 25.00K | 9.26% | $3.82M |
| Fulcrum asset management llp | 23.74K | 8.77% | $2.82M |
| Nordwand advisors | 335.85K | 8.05% | $51.30M |
| Clark & stuart | 51.92K | 6.88% | $9.63M |
| Slocum, gordon & co llp | 43.78K | 6.47% | $8.12M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Norges bank | 30.36M | 0.58% | 30.36M |
| Blackrock | 198.19M | 0.66% | 8.46M |
| Janus henderson group | 7.95M | 0.58% | 4.56M |
| Blackrock funding, inc. /de | 203.85M | 0.59% | 4.48M |
| Jpmorgan chase | 38.78M | 0.42% | 4.43M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Price t rowe associates inc /md/ | 16.28M | 0.27% | -8.88M |
| Legal & general group | 18.51M | 0.71% | -4.60M |
| Capital investors | 598.70K | 0.02% | -3.10M |
| Pacer advisors | 495.16K | 0.23% | -2.63M |
| Bank of new york mellon | 18.34M | 0.52% | -2.51M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Norges bank | 30.36M | 0.58% | 30.36M | $4.39B |
| Glenmede investment management, lp | 1.45M | 1.12% | 1.45M | $220.79M |
| Leigh baldwin | 933.78K | 0.81% | 933.78K | $933.78M |
| Fjarde ap-fonden (the fourth swedish national pensionfund) | 747.61K | 1.23% | 747.61K | $109.27M |
| Harding loevner lp | 579.18K | 0.60% | 579.18K | $88.48M |
Sold Out
| Holder | Change |
|---|---|
| Parallax volatility advisers | -1.00 |
| Vista private wealth partners. | -2.00 |
| Kessler investment group | -7.00 |
| Disciplined equity management | -11.00 |
| Thomas j. herzfeld advisors | -15.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 4,045 | -3.74% | 1,753,295,565 | 2.71% | 72 | 1.44% | 1,749 | -9.57% | 1,821 | - |
| Mar 31, 2025 | 4,137 | -0.29% | 1,703,397,235 | -1.50% | 70 | 1.37% | 1,902 | 7.34% | 1,795 | -6.99% |
| Dec 31, 2024 | 3,707 | -5.87% | 1,539,646,134 | -9.01% | 63 | 1.32% | 1,551 | -12.22% | 1,736 | 2.18% |
| Sep 30, 2024 | 3,871 | 0.81% | 1,686,691,500 | -1.16% | 69 | 1.38% | 1,745 | 7.12% | 1,661 | -6.05% |
| Jun 30, 2024 | 3,769 | -3.09% | 1,703,592,008 | 2.75% | 70 | 1.49% | 1,603 | -5.54% | 1,732 | 0.29% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard US Total Market Shares ETF | 76.28M | 3.17% | 79.81K |
| Vanguard Total Stock Mkt Idx Inv | 75.61M | 3.14% | -1.75M |
| Vanguard 500 Index Investor | 59.56M | 2.47% | -8.73M |
| Fidelity 500 Index | 30.50M | 1.27% | 13.10K |
| SPDR® S&P 500 ETF | 29.95M | 1.24% | -450.05K |
| SPDR® S&P 500® ETF Trust | 29.15M | 1.21% | -152.82K |
| SPDR® S&P 500® ETF | 29.06M | 1.21% | 357.49K |
| iShares Core S&P 500 ETF | 28.95M | 1.20% | - |
| Vanguard Value Index Inv | 21.33M | 0.89% | -25.14K |
| The Health Care Select Sector SPDR® ETF | 16.43M | 0.68% | 26.60K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Oct 17, 2025 | REED JOHN C | EVP, Innovative Medicine, R&D | Sell | $4.19M |
| Sep 04, 2025 | Taubert Jennifer L | EVP, WWC. Innovative Medicine | Sell | $10.04M |
| Aug 22, 2025 | Duato Joaquin | CEO and Chairman of the Board | Sell | $22.55M |
| Aug 15, 2025 | Wolk Joseph J | Exec VP, CFO | Sell | $2.98M |
| Jul 17, 2025 | REED JOHN C | EVP, Innovative Medicine, R&D | Sell | $3.13M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q3 | - | 4 |
| 2025 Q2 | - | - |
| 2025 Q1 | - | 3 |
| 2024 Q3 | - | 1 |
| 2024 Q2 | - | - |
JNJ Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools